Transforming Growth Factor-beta 1 in the Rat Brain: Increase After Injury and Inhibition of Astrocyte Proliferation
Overview
Authors
Affiliations
Transforming growth factor-beta 1 (TGF-beta 1) has been shown to up-regulate the synthesis of nerve growth factor (NGF) in cultured rat astrocytes and in neonatal brain in vivo (Lindholm, D., B. Hengerer, F. Zafra, and H. Thoenen. 1990. NeuroReport. 1:9-12). Here we show that mRNA encoding TGF-beta 1 increased in rat cerebral cortex after a penetrating brain injury. The level of NGF mRNA is also transiently increased after the brain trauma, whereas that of brain-derived neurotrophic factor remained unchanged. In situ hybridization experiments showed a strong expression of TGF-beta 1 4 d after the lesion in cells within and in the vicinity of the wound. Staining of adjacent sections with OX-42 antibodies, specific for macrophages and microglia/brain macrophages, revealed a similar pattern of positive cells, suggesting that invading macrophages, and perhaps reactive microglia, are the source of TGF-beta 1 in injured brain. Both astrocytes and microglia express TGF-beta 1 in culture, and TGF-beta 1 mRNA levels in astrocytes are increased by various growth factors, including FGF, EGF, and TGF-beta itself. TGF-beta 1 is a strong inhibitor of astrocyte proliferation and suppresses the mitotic effects of FGF and EGF on astrocytes. The present results indicate that TGF-beta 1 expressed in the lesioned brain plays a role in nerve regeneration by stimulating NGF production and by controlling the extent of astrocyte proliferation and scar formation.
Miyamoto T, Kuboyama K, Honda M, Ohkawa Y, Oki S, Sawamoto K Front Neurosci. 2025; 18():1504047.
PMID: 39840011 PMC: 11747130. DOI: 10.3389/fnins.2024.1504047.
Lekuya H, Cose S, Nakibuule M, Ahimbisibwe G, Fuller A, Kamabu L Front Neurol. 2025; 15:1484742.
PMID: 39744105 PMC: 11688224. DOI: 10.3389/fneur.2024.1484742.
Mohammad Z, Yudin S, Goldberg B, Serra K, Klegeris A Rev Neurosci. 2024; 36(1):91-117.
PMID: 39240134 PMC: 11717358. DOI: 10.1515/revneuro-2024-0081.
Goyal L, Singh S CNS Neurol Disord Drug Targets. 2024; 24(1):47-59.
PMID: 39082170 DOI: 10.2174/0118715273318552240708055413.
Han T, Song P, Wu Z, Liu Y, Ying W, Shen C Stem Cell Rev Rep. 2023; 19(6):2024-2037.
PMID: 37256514 PMC: 10390616. DOI: 10.1007/s12015-023-10560-y.